Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-30

Clinical Trial Update: Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial assessing donepezil effects on task-activated fMRI brain activation in healthy older adults at genetic risk for Alzheimer's disease; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil HCl (Donepezil hydrochloride)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Genetic Risk for Alzheimer's Disease | Phase 4 | Status: COMPLETED | Results posted: 2023-08-30